Ralf Hildenbrand

Lack of clinical efficacy of imatinib in metastatic melanoma

Selma Ugurel, Ralf Hildenbrand, A Zimpfer et al. · British Journal of Cancer · 2005 · 241 citations · Full text

Medicine, Clinical Sciences, Oncology +17

High Expression of Vascular Endothelial Growth Factor Predicts Early Recurrence and Poor Prognosis after Curative Resection for Ductal Adenocarcinoma of the Pancreas

Marco Niedergethmann, Ralf Hildenbrand, Birgit Wostbrock et al. · Pancreas · 2002 · 189 citations

Medicine, Oncology, Surgery +17

c-MYC Activation in Primary and Metastatic Ductal Adenocarcinoma of the Pancreas: Incidence, Mechanisms, and Clinical Significance

Christiane Schleger, Caroline S. Verbeke, Ralf Hildenbrand et al. · Modern Pathology · 2002 · 160 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Urokinase and macrophages in tumour angiogenesis

Ralf Hildenbrand, I. Dilger, A Hörlin et al. · British Journal of Cancer · 1995 · 119 citations · Full text

Medicine, Cell Biology, Oncology +12

Polo-like kinase: a novel marker of proliferation: Correlation with estrogen-receptor expression in human breast cancer

Georg Wolf, Ralf Hildenbrand, Christian Schwar et al. · Pathology - Research and Practice · 2000 · 111 citations

Medicine, Cancer Biology, Oncology +17